Psychiatry & Neurology Doctors in Greenfield, IN Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Benjamin Ethan Mcallister, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 120 W Mckenzie Rd Ste F, Greenfield, IN 46140 Phone: 317-468-6200    Fax: 317-468-6201

John D Chase, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave, Suite 100, Greenfield, IN 46140 Phone: 317-462-5252    Fax: 317-462-8010

Delynn M Williams, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 120 W Mckenzie Rd, Suite F, Greenfield, IN 46140 Phone: 317-468-6200    Fax: 317-468-6201

Melinda A. Cobb, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 120 W Mckenzie Rd, Suite F, Greenfield, IN 46140 Phone: 317-468-6200    Fax: 317-468-6201

Heather Renee Downhour, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 145 Green Meadows Drive, Suite 1, Greenfield, IN 46140 Phone: 317-462-1481

Dr. Stanley Joseph Szwast, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 801 N State St, Greenfield, IN 46140 Phone: 317-845-9233

News Archive

Engineered immune cells show antitumor activity in two patients with advanced cancers

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatments, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.

Synthetic Biologics begins SYN-004 Phase 2a clinical trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced the initiation of a Phase 2a clinical trial to evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent C. difficile infection (CDI).

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.

Gene therapy to improve ailing heart's contractions of muscle cells

Scientists from the Universities of Michigan and Minnesota show in a research report published online in the FASEB Journal (http://www.fasebj.org) that gene therapy may be used to improve an ailing heart's ability to contract properly. In addition to showing gene therapy's potential for reversing the course of heart failure, it also offers a tantalizing glimpse of a day when "closed heart surgery" via gene therapy is as commonly prescribed as today's cocktail of drugs.

Read more Medical News

› Verified 4 days ago